Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bombois

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
European Journal of Neurology|September 4, 2020
COVID-19-related encephalopathy: a case series with brain FDG-positron-emission tomography/computed tomography findingsC Delorme, O Paccoud, A Kas, et al.
La Revue De Medecine Interne|November 29, 2016
[Alzheimer's disease cerebro-spinal fluid biomarkers: A clinical research tool sometimes useful in daily clinical practice of memory clinics for the diagnosis of complex cases]E Magnin, J Dumurgier, E Bouaziz-Amar, et al.
Experimental Neurology|December 17, 2009
An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levelsA Petzold, M D Chapman, S Schraen, et al.
Molecular Psychiatry|September 26, 2007
Evidence for induction of the ornithine transcarbamylase expression in Alzheimer's diseaseF Bensemain, D Hot, S Ferreira, et al.
Molecular Psychiatry|April 5, 2012
High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer diseaseC Pottier, D Hannequin, S Coutant, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
European Journal of Neurology|September 4, 2020
COVID-19-related encephalopathy: a case series with brain FDG-positron-emission tomography/computed tomography findingsC Delorme, O Paccoud, A Kas, et al.
La Revue De Medecine Interne|November 29, 2016
[Alzheimer's disease cerebro-spinal fluid biomarkers: A clinical research tool sometimes useful in daily clinical practice of memory clinics for the diagnosis of complex cases]E Magnin, J Dumurgier, E Bouaziz-Amar, et al.
Experimental Neurology|December 17, 2009
An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levelsA Petzold, M D Chapman, S Schraen, et al.
Molecular Psychiatry|September 26, 2007
Evidence for induction of the ornithine transcarbamylase expression in Alzheimer's diseaseF Bensemain, D Hot, S Ferreira, et al.
Molecular Psychiatry|April 5, 2012
High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer diseaseC Pottier, D Hannequin, S Coutant, et al.
Pageof 3